Skip to content
Review Open access

Non-Contrast Fat-Saturated FLAIR MRI: Utility for Detecting Posterior and Seronegative-Associated Lesions in Optic Neuritis

Sep 2026 · Diagnostics · Vol 16 · 0 citations · 25 references
Medicine

Abstract

Background/Objectives: To compare the lesion detection rates of fluid-attenuated inversion recovery with fat saturation (FLAIR-FS) versus T2-weighted short tau inversion recovery (T2WI-STIR) and contrast-enhanced T1-weighted imaging (CE-T1WI) in detecting lesions across antibody-defined subtypes (AQP4-ON, MOG-ON, seronegative ON) and anatomic segments of optic neuritis (ON). Methods: Forty-two patients (56 eyes) aged 5–57 years with acute/subacute optic neuritis underwent orbital MRI (T2WI-STIR, FLAIR-FS, and CE-T1WI). Two blinded neuroradiologists independently reviewed the images to assess lesion detectability and inter-observer reliability (kappa statistics). Generalized estimating equations (GEE) were used to account for within-patient correlation, with Bonferroni correction for pairwise comparisons. Results: FLAIR-FS demonstrated the highest detection rate (96.4%, 54/56 eyes), numerically higher than T2WI-STIR (80.4%, 45/56 eyes; corrected p = 0.051) and significantly higher than CE-T1WI (76.8%, 43/56 eyes; corrected p = 0.006). Inter-observer agreement was highest for FLAIR-FS (κ = 0.791), followed by CE-T1WI (κ = 0.729) and T2WI-STIR (κ = 0.681). In the posterior visual pathway, FLAIR-FS detected significantly more lesions than T2WI-STIR (corrected p = 0.024) and CE-T1WI (corrected p = 0.024). The Sequence × ON subtype interaction was not significant (p = 0.158); descriptively, FLAIR-FS showed the highest detection rate across all subtypes. Conclusions: FLAIR-FS demonstrated the highest lesion detection rate among the three sequences, particularly in the posterior visual pathway. FLAIR-FS should be regarded as a useful complementary non-contrast sequence, particularly when gadolinium cannot be administered.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.